News

Filter

Current filters:

GenentechArzerra

GSK settles with Genentech over ofatumumab patents

28-03-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed a settlement with Genentech, a unit of Roche (ROG:…

ArzerraBiotechnologyGenentechGenmabGlaxoSmithKlineLegalOfatumumab InjectionOncologyPatentsPharmaceuticalRoche

US court rules in GlaxoSmithKline’s favor in Arzerra patent dispute

18-11-2011

A US District Court has entered final judgment in favor of UK pharma giant GlaxoSmithKline (LSE: GSK)…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceuticalRoche

Genentech and Biogen sue GlaxoSmithKline and Genmab over Arzerra patent

26-03-2010

US biotechnology giant Genentech, a wholly-owned subsidiary of Switzerland’s Roche, and Biogen Idec…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineOncologyPatentsPharmaceuticalRituxanRoche

COMPANY SPOTLIGHT

Menarini

Back to top